Sen, N. Et Al. 2023. Anti-mutated citrulline vimentin antibodies may be higher in Ankylosing spondylitis, but may not have a role in diagnosing disease and may not be associated with disease severity. Northern Clinics of Istanbul , vol.10, no.3 , 328-334.

Sen, N., KAÇAR, C., ÖZDEM, S., Uzun, G., & Tezcan, M. E., (2023). Anti-mutated citrulline vimentin antibodies may be higher in Ankylosing spondylitis, but may not have a role in diagnosing disease and may not be associated with disease severity. Northern Clinics of Istanbul , vol.10, no.3, 328-334.

Sen, Nesrin Et Al. "Anti-mutated citrulline vimentin antibodies may be higher in Ankylosing spondylitis, but may not have a role in diagnosing disease and may not be associated with disease severity," Northern Clinics of Istanbul , vol.10, no.3, 328-334, 2023

Sen, Nesrin Et Al. "Anti-mutated citrulline vimentin antibodies may be higher in Ankylosing spondylitis, but may not have a role in diagnosing disease and may not be associated with disease severity." Northern Clinics of Istanbul , vol.10, no.3, pp.328-334, 2023

Sen, N. Et Al. (2023) . "Anti-mutated citrulline vimentin antibodies may be higher in Ankylosing spondylitis, but may not have a role in diagnosing disease and may not be associated with disease severity." Northern Clinics of Istanbul , vol.10, no.3, pp.328-334.

@article{article, author={Nesrin Sen Et Al. }, title={Anti-mutated citrulline vimentin antibodies may be higher in Ankylosing spondylitis, but may not have a role in diagnosing disease and may not be associated with disease severity}, journal={Northern Clinics of Istanbul}, year=2023, pages={328-334} }